Extremity Peripheral Arterial Occlusive Disease Research Articles

Preoperative Sizing to Lower In-Stent Restenosis in Peripheral Arterial Occlusive Disease

ObjectivesThe primary treatment for lower extremity peripheral arterial occlusive disease (PAOD) is angioplasty-stenting. Its main complication is in-stent restenosis. Poor selection of stent dimensions has been identified as a factor contributing to early in-stent restenosis. The aim of this study is to determine whether the implantation of stents, selected based on arterial morphological reconstruction using sizing software, reduces the occurrence of in-stent restenosis. The study also aims to evaluate the potential benefits of routine preoperative sizing. MethodsBetween January 2016 and December 2020, all patients treated for PAOD through scheduled angioplasty-stenting in our department were included in the study. Using systematic preoperative Computed Tomography Angiography (CTA), precise reconstruction and sizing were performed to select the ideal length and diameter of stents, resulting in the selection of a so-called IDEAL stent. During the procedure, the surgeon implanted either the IDEAL stent or a different one, named the ACTUAL stent, based on intraoperative data and/or availability. We compared the in-stent restenosis rate between IDEAL and ACTUAL stents. ResultsThere were no significant differences in the overall characteristics between the IDEAL and ACTUAL stent groups. The in-stent restenosis rate at one year was 13% (N=28/212, P=0.994) in the IDEAL group and 17% (N=25/149, P=0.994) in the ACTUAL group. Among the ACTUAL stents, a total of 19.6% of stents with a diameter mismatch when chosen based on arteriography showed a significantly higher restenosis rate during the first year of follow-up (P=0.02). ConclusionsOur study did not demonstrate a significant difference in 1-year restenosis rate between the IDEAL and the ACTUAL stents groups. It specifically revealed the significant impact of diameter selection on the intrastent restenosis rate during the first year of follow-up. Stents chosen based on arteriographic criteria, which exhibited diameter discordance, compared to the IDEAL stents group selected using sizing reconstructions, could be either oversized or undersized. This led to a significantly higher restenosis rate at 1 year postoperative.

Assessment of anxiety and health-related quality of life in patients with lower extremity peripheral arterial occlusive disease.

IntroductionThe aim of this study was to investigate the effect of chronic occlusive vascular disease on anxiety with adverse outcome with health-related quality of life (HRQoL).Material and methodsThree hundred and thirty-five patients who were treated for peripheral arterial occlusive disease were enrolled in this study. 187 patients who had undergone percutaneous transluminal angioplasty and 148 patients who had one or more surgical revascularizations enrolled in the study. Mean age of the patients was 62.6 ±10 years. Two hundred and eighty-nine patients were male, 46 patients were female. Physical and mental domains of quality of life were measured using the 36-item Medical Outcomes Short-Form Health Survey (SF-36) self-administered questionnaire and anxiety symptoms were assessed using the Spielberger State-Trait Anxiety Inventory (STAI). At baseline 335 patients filled out the SF-36 and STAI, and 304 patients (90.7 % of the series) filled them out at 6-month follow-up.ResultsThere was no mortality and no significant morbidity after vascular interventions in the series. Significant improvement was found in two of eight health domains. The score of social functioning increased to 60.4 from 52.6 (p < 0.03) and general health perception increased to 75.1 from 60.5 (p < 0.04) at 6-month follow-up. The two STAI sub-scores, the State Anxiety Inventory (STAI-S) and the Trait Anxiety Inventory (STAI-T) were found high (≥ 40) both preoperatively and 6 months postoperatively. Postoperatively there was no significant decrease of the levels of anxiety.ConclusionsThis study suggests that the assessment of psychosocial factors, particularly the ongoing assessment of anxiety, could help in risk stratification and prediction of functional status in patients suffering from lower extremity peripheral arterial occlusive disease.

The disproportionate growth of office-based atherectomy

ObjectiveThe purpose of this study was to evaluate the trends in procedure volume, clinical sites of care, and Medicare expenditure for peripheral vascular interventions (PVIs) for lower extremity occlusive disease since the Centers for Medicare and Medicaid Services instituted reimbursement policy changes that broadened payment for procedures performed in physician-owned office-based laboratories (OBLs). MethodsWe analyzed fee-for-service Medicare claims data from 2011 to 2014 to obtain the frequency of use of PVI by type, care setting, and physician specialty. We also assessed changes in the total Medicare cost for PVI by setting. ResultsThere was a 60% increase in atherectomy cases among Medicare beneficiaries between 2011 and 2014. During the same period, OBLs experienced a 298% increase in atherectomy volume vs a 27% increase in hospital outpatient settings and an 11% decrease for inpatient hospital settings. In 2014, OBLs were the most common setting for atherectomy. Nonatherectomy PVIs grew more modestly at just 3% but also experienced site of care shifts. Vascular surgeons and cardiologists accounted for the majority of office-based PVIs in 2014. Total Medicare costs for PVIs increased 18% from 2011 to 2014. Hospital inpatient costs declined 1%, whereas costs for hospital outpatient PVIs increased by 41% and physician office costs increased by 258%. ConclusionsThe migration of revascularization procedures for lower extremity peripheral arterial occlusive disease continues from the inpatient to the outpatient setting and especially to OBLs. Increased use of atherectomy in all segments of the lower extremity arterial system has been observed, particularly in OBLs, without substantial evidence in the literature of increased efficacy compared with standard angioplasty with or without stenting. Generous Medicare reimbursement for in-office atherectomy procedures is likely contributing to the volume shifts observed.

Percutaneous Treatment of Superficial Femoral Artery Stenosis Secondary to Radiation Arteritis

Radiation arteritis is a rare cause of lower extremity peripheral arterial occlusive disease, and has been traditionally treated with open interventions. There have been only a few reported cases of endovascular interventions for this disease. Previous reports described endovascular treatment in the iliac and common femoral regions, but intervention in the superficial femoral artery have not been described. Described here is a case of acute lower extremity ischemia caused by remote radiation arteritis of the superficial femoral artery, which was successfully treated by percutaneous endovascular technique.

Alt Ekstremite Periferik Tıkayıcı Arter Hastalıklarında Renkli Doppler Ultrasonografi ve Üç Boyutlu MR Anjiografi ile Dijital Subtraksiyon Anjiografi Yöntemlerinin Karşılaştırılması

Alt Ekstremite Periferik Tıkayıcı Arter Hastalıklarında Renkli Doppler Ultrasonografi ve Üç Boyutlu MR Anjiografi ile Dijital Subtraksiyon Anjiografi Yöntemlerinin Karşılaştırılması

Factors related to the degree of lower extremity peripheral arterial occlusive disease in post-stroke dementia

Background/Objective: A low ankle-brachial index (ABI) is associated with an increased risk of peripheral artery disease, cardiovascular disease and stroke. Limited data exist regarding the relation between a low ABI and dementia with cerebrovascular disease patients.

Overview of New Technologies for Lower Extremity Revascularization

Lower extremity peripheral arterial occlusive disease poses a unique challenge to traditional angioplasty-based endovascular therapies. The diffuse nature of lower extremity atherosclerotic disease, the presence of chronic total occlusions, poor distal runoff, and the presence of critical limb ischemia all have contributed to the disappointing results of balloon angioplasty for complex infrainguinal arterial disease. These challenges have spawned the development of a host of new technologies in an attempt to improve the safety and effectiveness of percutaneous revascularization for lower extremity peripheral arterial occlusive disease. This review summarizes the recent advances in available technologies, including novel angioplasty balloons; nitinol stents, stent grafts, and drug-eluting stents; excisional, laser, and rotational atherectomy devices; devices for crossing total occlusions; true-lumen reentry devices; thrombectomy catheters; and embolic protection devices.

Fluoroscopic Contrast-Enhanced MR Angiography with a Magnetization-Prepared Steady-State Free Precession Technique in Peripheral Arterial Occlusive Disease

The objective of our study was to evaluate the feasibility of intraarterial (IA) near-real-time contrast-enhanced MR angiography (CE-MRA) with a frame rate of 1.3 frames per second in seven patients with lower extremity peripheral arterial occlusive disease (PAOD). For optimized background suppression, a modified 2D steady-state free precession (SSFP) technique with magnetization preparation and mask subtraction was developed. The femoropopliteal and infrapopliteal arteries were covered in two separate steps. Acceptable contrast-to-noise ratios were obtained, and road maps were reconstructed from the same data set. Mastering IA near-real-time CE-MRA, including road map reconstruction, with an SSFP technique in the lower extremity of patients with PAOD is an important building block toward successfully performing endovascular catheter MR-guided interventions.